Skip to Main Content
WITH HYDROLOCK TECHNOLOGY

Exufiber Ag+

Leakage. Maceration. Infection. Key challenges for gelling fiber dressings which can impact healing, cause anxiety and pain for the patient, and take up nurse time.  

Exufiber® Ag+ with Hydrolock® Technology has superior* ability to lock in exudate, even under compression...     

Discover Exufiber Ag+
99.9%

Reduction in Pseudomonas aeruginosa over seven days in an in vivo biofilm model  

up to 23%

more exudate absorbed and locked in than Aquacel® Ag Extra™  

98%

of clinicians rated Exufiber as easy or very easy to remove in one piece   

Mepilex Border Flex Folded corner

Exufiber Ag+® with Mepilex® Border Flex

Mepilex Border Flex combines innovative Flex Technology with our proven Safetac® Technology to create a secondary dressing that stays on and is uniquely conformable. Using Exufiber Ag+ and Mepilex Border Flex together delivers the benefits of both dressings and promotes an undisturbed healing environment for the wound.

Learn more about Mepilex Border Flex

Cost-effective wound care
health care professional speaking with a sales person

Chronic wounds take time to heal. Infection adds to the challenge. The presence of biofilm can delay healing by keeping the wound in an inflammatory state, and making the bacteria tolerant to treatment. Management of leakage, residue and maceration plus the challenge of high bioburden requires nurse time and resources. The superior* exudate management and antibiofilm action** of Exufiber® Ag+ combine to deliver a dressing that potentially can support undisturbed healing as well as influencing costs.

Talk to us about how Exufiber Ag+ can make a difference to your patients, team and budget.

Contact your local Mölnlycke representative

'References'

Select market

Select your market

Mölnlycke Copy

Healthcare Professional Confirmation

The information on the page you are about to enter is intended for healthcare professionals only. By clicking the box below you confirm that you are a healthcare professional.